Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors
摘要:
Starting from a series of ureas that were determined to be mechanism-based inhibitors of FAAH, several spirocyclic ureas and lactams were designed and synthesized. These efforts identified a series of novel, noncovalent FAAH inhibitors with in vitro potency comparable to known covalent FAAH inhibitors. The mechanism of action for these compounds was determined through a combination of SAR and co-crystallography with rat FAAH. (C) 2011 Elsevier Ltd. All rights reserved.
Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors
摘要:
Starting from a series of ureas that were determined to be mechanism-based inhibitors of FAAH, several spirocyclic ureas and lactams were designed and synthesized. These efforts identified a series of novel, noncovalent FAAH inhibitors with in vitro potency comparable to known covalent FAAH inhibitors. The mechanism of action for these compounds was determined through a combination of SAR and co-crystallography with rat FAAH. (C) 2011 Elsevier Ltd. All rights reserved.
Identification of potent, noncovalent fatty acid amide hydrolase (FAAH) inhibitors
作者:Darin J. Gustin、Zhihua Ma、Xiaoshan Min、Yihong Li、Christine Hedberg、Cris Guimaraes、Amy C. Porter、Michelle Lindstrom、Dianna Lester-Zeiner、Guifen Xu、Timothy J. Carlson、Shouhua Xiao、Cesar Meleza、Richard Connors、Zhulun Wang、Frank Kayser
DOI:10.1016/j.bmcl.2011.02.052
日期:2011.4
Starting from a series of ureas that were determined to be mechanism-based inhibitors of FAAH, several spirocyclic ureas and lactams were designed and synthesized. These efforts identified a series of novel, noncovalent FAAH inhibitors with in vitro potency comparable to known covalent FAAH inhibitors. The mechanism of action for these compounds was determined through a combination of SAR and co-crystallography with rat FAAH. (C) 2011 Elsevier Ltd. All rights reserved.